Wednesday, October 27, 2021

Novartis works with app maker to help eye patients ‘See What’s Next’

Novartis wants to help patients overcome the hurdles in specialized eye disease treatment with the help of a new digital tool.

The Swiss drugmaker worked with disease management app company smartpatient to create an adherence and education module inside the MyTherapy app specifically for wet age-related macular degeneration (AMD) patients. Called “See What’s Next,” the new feature includes information and resources to help patients better understand and manage their condition.

Sponsored by Clinical Ink

Deploy Configurable, Fit-for-Purpose ePRO Solutions, Fast.

Clinical Ink’s enhanced Lunexis™ ePRO+ module streamlines processes through a flexible, unified platform that allows patients and sites a high degree of optionality.

Novartis initially reached out to smartpatient when it noticed a pattern of patients who would come in for one or two injections of its anti-vascular endothelial growth factor therapy treatment Beovu, but not return.

Any AMD patient can access the module with a link from their ophthalmologist. “See What’s Next” is currently available in Italy and Spain, with plans to eventually expand to the U.S. and other regions.

RELATED: Novartis, stressing Beovu safety, matches Eylea in head-to-head diabetic macular edema trial

While the obvious deterrent to the Beovu AMD treatment is a needle stick to the eye to administer the drug, other less apparent hurdles include a lack of understanding and education. There are a limited number of retinal specialists in AMD and thus a dearth of education about the disease, smartpatient CEO Sebastian Gaede said.

Gaede was impressed that Novartis wanted the platform to not just focus on its products, but become an educational tool for everyone living with AMD. Other treatments for wet AMD include Regeneron’s Eylea, Novartis’ chief competitor.

The MyTherapy app is a fast-growing medication disease management app with partners including Novartis, Pfizer and Merck. The app’s goal is to offer one place for all a patient’s health needs across multiple treatments and conditions, Gaede said. He describes MyTherapy as a “to-do list” for disease management, covering pill schedules, appointments and healthy activities.

While other health pharma apps have struggled to connect with users, the average MyTherapy user is active three times a day, Gaede said. It was that idea of adherence that Gaede, a trained economist, was interested in.

RELATED: Why don’t patients love pharma apps? Because most are just mediocre, advocacy network says

“This kind of behavioral challenge just struck me that people are making decisions which are so much to their disadvantage, and we get to the disadvantage of not only them personally but also to the society and healthcare of all and, and in many cases, those decisions are driven by a lack of understanding,” he said.

There are more pharma-connected modules for the app on the way, and, while Gaede declined to talk specifics, he did say he is talking to companies working in oncology, women’s health and even virtual trials.

“Pharma is realizing that digital does have the opportunity to really improve outcomes and create a measurable impact on outcomes,” he said.

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...